Antibe Therapeutics Inc(Pre-Merger) ATBPF

Disappointed

[Forestview]

This will certainly kill the momentum, and it feels like after we left the $4 invisible wall behind, we now have one at $6.  But, I suspect this was in the works before the Nuance deal was announced, so perhaps they didnt realize the share price would be where it was, and the momentum was building.  But, it does feel like a another set back, with more dilution.  

Even though I thought the plan was to have another drug company take Otena through Phase 3, I guess they wanted to show that THEY COULD do it if they had to.  But still.  Not happy with this.  I think we will be mired in the $5.80 to $6.20 range for the foreseeable future.

[RalphRalph]

Agree - management has done two bought deals at low valuations in the past 9 months - each time diluting by about 25%.  That level of dilution in 9 months is not effective management.  And they still have not been able to offload Citagenix.     Of course it strengthens their negotiating position - but it does so at immense cost to shareholders.  Each raise lowers